Curriculum Vitae

PROF. DR. GAN SHIAW SZE @ GAN GIN GIN

Professor
  • Department of Medicine
    Faculty of Medicine
  • gangg
  • 03-79492429

BIOGRAPHY


Professor Dr Gan Shiaw Sze @ Gan Gin Gin is a Professor in Internal Medicine and Clinical Haematology, Department of Medicine, Faculty of Medicine, University of Malaya. She graduated with honours from University of New South Wales, Australia and joined the Department of Medicine, University of Malaya as a lecturer in 2000 after obtaining her MRCP (UK) qualification. In addition to this, she is also a fellow of Academy of Medicine, fellow of Royal College of Physicians, Edinburgh (UK).  Believing in further improving herself, she obtained a Master’s degree with distinction in Clinical Medicine (Leadership & Management) from the University of Newcastle, Australia in 2017, which subsequently offers her the position of conjoint adjunct associate professor in 2020

She was the head of the division of clinical haematology in Department of Medicine, (2003 to 2018) and was instrumental in the improvement of haematology daycare services and expanding the haematology clinical services including haematopoietic stem cell transplantation in University Malaya Medical Centre. She is in fact the first haematologist to perform matched unrelated donor haematopoietic stem cell transplantation in an adult patient in Malaysia. She has also written many guidelines for haematological procedures for University Malaya Medical Centre (UMMC) and spearheaded the well-integrated medical daycare area.

Professor Gan is active in Malaysian Society of Haematology where she held the position of honorary secretary (2004 to 2008) and council member (2008-2018). She is currently Vice President of the society (2020-2022). She has played a key role in shaping the training of clinical haematologists in Malaysia. She is the national chair of the Examination Subcommittee, past chairperson and current committee member of clinical haematology training in Malaysia. In addition, she is also one of the members of Malaysian Medical Council Education Specialty Sub-Committee for clinical haematology. Not only is she involved in subspecialty training, she is also active in undergraduate and postgraduate medical training and is the chair for the haematology block for undergraduate medical degree in University Malaya. She continues to actively mentor undergraduate and postgraduate students, trainees and doctorate students.

Professor Gan has contributed much to the transfer of her expertise and knowledge in her capacity as a national committee/panel member for formulating clinical practice guidelines on management of blood disorders and national policies on stem cell transplantation, which have served as reference nationwide. She is also actively involved in organizing national conferences and workshops for the continuous professional development for trainees and students. She has been invited to evaluate numerous grants, namely FRGS, UMSC C.A.R.E. fund and Newton Fund. At the international level, she has been a reviewer for many ISI (WOS) publications. Internationally, she is a respected member in the field of haematology. She is involved in many advisory boards and is part of expert panel members and steering committee of Asian Myeloma Network and Asia Pacific Myeloma & Related Diseases Registry.  She is also one of the scientific committee members for Asia Pacific Blood and Marrow Transplantation Group (APBMT).

Her interest in research, especially in genetic polymorphisms associated with haematological related diseases, haematopoietic stem cell transplantation, lymphoma and myeloma has resulted in numerous publications in peer-reviewed journals. Besides this, she is actively involved in multiple international clinical trials. 

She has been engaged as speaker, chairperson for many workshops/seminars and conferences. Apart from that, she has also been awarded several times of excellent service awards for her contributions to academic services and clinical services at the University of Malaya.

AREAS OF EXPERTISE


  • GENERAL HAEMATOLOGY, HAEMATOLOGY-ONCOLOGY, HAEMOPOEITIC STEM CELL TRANSPLANTATION

ACADEMIC QUALIFICATION


  • M.Clinical Medicine (Leadership&Management), (CLINICAL MEDICINE (LEADERSHIP AND MANAGEMENT))
    University of Newcastle, Australia
  • FRCP, (Frcp)
    Royal College of Physicians of Edinburgh, United Kingdom
  • MRCP, (HEMATOLOGI)
    Royal College of Physicians
  • MBBS(NSW), (Medicine, Obstetrics and Surgery)
    University of New South Wales, Australia
  • SIJIL, (Lain-Lain)
    Sijil Am Pelajaran (Kertas Julai)

ADMINISTRATIVE DUTIES


  • Head of Department
    01 Jan 2024 - present (Department of Medicine, Faculty of Medicine)
  • Quality Manager
    01 Jun 2012 - present (Department of Medicine, Faculty of Medicine)
  • Coordinator
    01 Jan 2015 - 30 Jun 2024 (Dean Office, Faculty of Medicine)
  • committee member JKKU KKM
    01 Nov 2020 - 31 Dec 2022 (National)
  • disciplinary panel member for MMC
    22 Aug 2019 - 31 Jul 2022 (National)
  • ahli jawatankuasa semakan kurikulm MBBS
    14 Apr 2021 - 01 Apr 2022 (Dean Office, Faculty of Medicine)
  • committee for transfusion medicine, UMMC
    01 Oct 2020 - 31 Oct 2021 (University Malaya)
  • mygrants panel
    25 Feb 2021 - 21 Mar 2021 (University Malaya)
  • medical daycare head
    01 Feb 2019 - 31 Jan 2021 (Department of Medicine, Faculty of Medicine)
  • block chair for haematology
    01 Jul 2014 - 30 Aug 2020 (Department of Medicine, Faculty of Medicine)
  • national transplant registry
    02 Apr 2018 - 31 Mar 2020 (National)
  • mygrants panel
    26 Feb 2020 - 04 Mar 2020 (University Malaya)
  • pemilih pelantikan pensyarah fakulti perubatan
    01 May 2018 - 31 Dec 2019 (Department of Medicine, Faculty of Medicine)
  • Head of Unit
    01 Jan 2016 - 31 Dec 2018 (Department of Medicine, Faculty of Medicine)
  • Programme Coordinator
    01 Jan 2016 - 31 Dec 2018 (Dean Office, Faculty of Medicine)
  • semakan semula guidelines on stem cell committee member
    01 Aug 2018 - 31 Dec 2018 (National)
  • committee member for national curriculum for clinical master of internal medicine
    01 Apr 2018 - 31 Dec 2018 (University Malaya)
  • KKM senari ubat haematology
    22 Aug 2016 - 31 May 2018 (National)
  • Deputy Head
    01 Feb 2018 - 15 May 2018 (Department of Medicine, Faculty of Medicine)
  • Head of Unit
    01 Jan 2002 - 01 Jan 2018 (Department of Medicine, Faculty of Medicine)
  • internal examiner
    08 May 2017 - 08 May 2017 (University Malaya)
  • mygrants
    07 Jan 2017 - 18 Feb 2017 (University Malaya)
  • Head Coordinator
    01 May 2013 - 30 Apr 2015 (Department of Medicine, Faculty of Medicine)
  • Programme Coordinator
    01 Apr 2013 - 01 Mar 2015 (Department of Medicine, Faculty of Medicine)
  • Programme Coordinator
    15 Aug 2011 - 31 Mar 2013 (Department of Medicine, Faculty of Medicine)
  • head of unit haematology in department of medicine
    01 Jan 2004 - 31 Dec 2011 (Department of Medicine, Faculty of Medicine)
  • coordinator for phase 3B MBBS
    01 Jan 2008 - 28 Apr 2010 (Department of Medicine, Faculty of Medicine)
  • coordinator for MBBS exam phase 3B for department of medicine
    01 Jan 2002 - 31 Dec 2002 (Department of Medicine, Faculty of Medicine)

MEMBERSHIPS


  • TOGETHER AGAINST CANCER ASSOCIATION MALAYSIA, MEMBER
    Since 2021 (National)
  • MALAYSIAN SOCIETY OF HAEMATOLOGY, VICE PRESIDENT
    Since 2020 (National)
  • ACADEMY OF MEDICINE, FELLOW
    Since 2019 (National)
  • MALAYSIAN SOCIETY OF HAEMATOLOGY , MEMBERS FOR LIFE
    Since 2018 (National)
  • MALAYSIAN SOCIETY OF HAEMATOLOGY, COUNCIL MEMBER
    Since 2016 (National)
  • MALAYSIAN SOCIETY OF HAEMATOLOGY, ACTIVE MEMBER
    Since 2001 (National)
  • HONORARY MEMBER, MEMBER
    2021 to 2022 (International)
  • APBMT, COMMITTEE MEMBER
    2021 to 2022 (International)
  • NATIONAL SPECILIAST REGISTRY, MEMBER
    2007 to 2022 (National)
  • AMERICAN SOCIETY FOR TRANSPLANTATION AND CELLULAR THERAPY, ACTIVE MEMBER
    2020 to 2021 (International)
  • ASIA PACIFIC BLOOD AND MARROW TRANSPLANTATION GROUP, MEMBER
    2020 to 2021 (International)
  • AMERICAN SOCIETY OF HEMATOLOGY, MEMBER
    2008 to 2021 (International)
  • MALAYSIAN SOCIETY OF HAEMATOLOGY, ASSESSMENT
    2019 to 2020 (National)
  • NATIONAL TRANSPLANT REGISTRY, EXPERT PANEL MEMBER
    2018 to 2020 (National)
  • MALAYSIAN MEDICAL ASSOCIATION, MEMBER
    2001 to 2020 (National)
  • MALAYSIAN SOCEITY OF HAEAMTOLOGY , ORGANISING CHAIRPERSON
    2019 to 2019 (National)
  • APBMT , MEMBER
    2019 to 2019 (International)
  • MINISTRY OF HEALTH , EXPERT PANEL MEMBER
    2018 to 2019 (National)
  • ACADEMY OF MEDICINE , MALAYSIA , PANEL MEMBER
    2018 to 2019 (National)
  • ACADEMY OF MEDICINE OF MALAYSIA, MEMBER
    2005 to 2019 (National)
  • ROYAL COLLEGE OF PHYSICIAN EDINBURG, MEMBER
    2016 to 2018 (International)
  • NATIONAL TRANSPLANT REGISTRY ( BLOOD AND MARROW SECTION), PANEL MEMBER
    2007 to 2018 (National)
  • ACADEMY OF MEDICINE, FELLOW MEMBER
    Since 2001 (National)
  • NATIONAL TRANSPLANT REGISTRY , COMMITTEE MEMBER
    2012 to 2017 (University)

AWARD AND STEWARDSHIP


  • appreciation as UMSC panel reviewer
    University of Malaya , Faculty of medicine, 2021 (University)
  • certificate of participation as speaker
    Unievrsity Malaya, UMCRI, 2021 (University)
  • certificate as speaker on CML
    5th Asean Federation of Haematology , 2020 (International)
  • Ahli jawatankuasa kerja ubat-ubatan JKKU Hematologi
    Ministry of health, Malaysia, 2020 (Government)
  • subspecialty education subcommittes for clinical hematology
    Malaysian medical council, 2020 (Government)
  • vice president
    Malaysian society of haematology, 2020 (National)
  • chairperson
    Malaysian society of haematology, 2020 (National)
  • certificate for speaker
    University of Malaya , Faculty of medicine adn malaysian oncology society , 2020 (Ptj/ Faculty)
  • appreciation of UMSC fund reviewer
    University of Malaya , Faculty of medicine, 2020 (Ptj/ Faculty)
  • EXCELLENCE SERVICE AWARD
    University of Malaya, 2020 (University)
  • KHIDMAT SETIA 20 AWARD
    University of Malaya, 2020 (University)
  • certificate of appreciation as speaker
    Malaysian Medics International, 2019 (National)
  • letter as speaker
    Postgraduate society of Haematology, 2019 (Government)
  • certificate as organiser for updates in haematology
    Malaysian society of haematology, University of Malaya Faciulty , 2019 (National)
  • certificate of appreciation as speaker
    Malaysian society of haematology16th MSH annual scientific meeting , 2019 (Private)
  • Certificate as speaker
    5th Asean Federation of Haematology , 2019 (International)
  • certificate of appreciation as organizing committee
    University of Malaya , Faculty of medicine and Malasysian Society of Haematology, 2019 (Ptj/ Faculty)
  • certificate of appreciation
    Unievrsity Malaya, UMCRI, 2019 (University)
  • best clinical award
    Malaysian society of haematology , 2019 (National)
  • reviewer award
    singapore medical journal, 2019 (International)
  • certificate as speaker for MSCT
    University of Malaya , Faculty of medicine and Malaysian oncology society , 2018 (University)
  • Expert panel of National Transplant registry
    National transplant registry , 2018 (National)
  • certificate appreciation as speaker for 52nd Malaysia-Singapore congress of medicine
    Academy of Medicine, malaysia,. Academy of medicine, Singapore, Hong Kong Academy of Medicine , 2018 (National)
  • panel pakar penasihat pihak berkuasa kawalan dadah
    Ministry of health, 2018 (Government)
  • certificate of appreciation research exhibition
    University of Malaya , Department of medicine, 2018 (Department)
  • certificate of appreciation for speaker
    University of Malaya , Faculty of medicine and Malaysian oncology society , 2018 (Ptj/ Faculty)
  • Bronze award for clinical abstract
    Malaysian Society of Haematology, 2018 (National)
  • recognition for speaker at national stem cell seminar
    Malaysian society for stem cell research and therapy, 2017 (National)
  • certificate appreciation/recognition as speaker
    University of Malaya , Faculty of medicine and Malasysian Society of Haematology, 2017 (Ptj/ Faculty)
  • Appreciation as speaker
    Malaysian society of haematology, 2016 (National)
  • Appreciation as chairperson
    Malaysian society of haematology, 2016 (National)
  • abstract reviewer
    Malaysian society of haematology, 2016 (National)
  • EXCELLENCE SERVICE AWARD
    University of Malaya, 2016 (University)
  • appreciation as chairperson
    Malaysian society of haematology, 2015 (National)
  • Appreciation as chairperson
    Asian Fungal working group and Pfizer, 2015 (National)
  • Appreciation as speaker
    Malaysian society of haematology, 2014 (National)
  • Outstanding Poster award
    Malaysian Society of Haematology, 2014 (National)
  • national workshop for restructuring of master of medicine ( internal medicine) program
    Ministry of health, Malaysia, Conjoint board, Academy of Medicine, 2013 (National)
  • Appreciation as speaker
    Malaysian society of haematology, 2013 (National)
  • EXCELLENCE SERVICE AWARD
    University of Malaya, 2013 (University)
  • appreciation as speaker
    Malaysian society of haematology, 2012 (National)
  • EXCELLENCE SERVICE AWARD
    University of Malaya, 2010 (University)
  • Best Poster
    malaysian society of Haematology, 2008 (National)
  • Appreciation in stem cell policy
    Ministry of health, 2007 (Government)
  • participation for seminar penyelidikan
    University of Malaya , 2006 (University)
  • appreciation as speaker
    University of Malaya Faculty of dentistry, 2005 (Ptj/ Faculty)
  • CERTIFICATE OF EXCELLENT SERVICE
    University of Malaya, 2005 (University)
  • EXCELLENCE SERVICE AWARD
    University of Malaya, 2003 (University)
  • Young investigator stipend award
    pan pacific lymphoma conference, 2003 (International)

PUBLICATIONS


Article in Journal
  1. Ahmad Khusairy Zulpa, Barathan Muttiah, Thevambiga Iyadorai, Chandramathi Samudi, Kumutha Malar, Jamuna Vadivelu, Gin-Gin Gan. Release of pro-inflammatory cytokines TNF- , IFN- and IL-6 by Burkholderia pseudomallei- stimulated peripheral blood mononucleocytes of acute myeloid leukemia patients. Tropical Biomedicine 2021
  2. Gan GG, Ng DLC, Leong YC. (2021). Erectile dysfunction in male lymphoma survivors in a Southeast Asian country. Singapore Med J. Online publication. doi: 10.11622/smedj.2021003.
  3. Sthaneshwar P, Thambiah SC, Mat Salleh MJ, Nasaruddin DS, Ahmad Zabidi NF, Jelani AM, Ismail AM, , Lai LC, Gan GG. Survey on serum protein electrophoresis and recommendations for standardized reporting. Malaysian J Pathol, 2021
  4. Anuar NA, Tey KWF, Ng SC, Teh AKH, Abdul Rahman MHF, Chong BP, Gan GG. (2020) Outcomes of high dose therapy and autologous haematopoietic stem cell transplantation for non-hodgkin lymphoma: A retrospective analysis in a resource-limited country. Int J Clin PractNov 17:e13823. doi: 10.1111/ijcp.13823.
  5. Ng, D. L., Malik, N., Chai, C. S., Goh, G. M., Tan, S. B., Bee, P. C., Gan, G. G., & Said, A. B. (2020). Time in therapeutic range, quality of life and treatment satisfaction of patients on long-term warfarin for non-valvular atrial fibrillation: a cross-sectional study. Health and quality of life outcomes, 18(1), 347. https://doi.org/10.1186/s12955-020-01600-z
  6. Ting, C. Y., Gan, G. G., Bee-Lan Ong, D., Tan, S. Y., & Bee, P. C. (2020). Extranodal site of diffuse large B-cell lymphoma and the risk of R-CHOP chemotherapy resistance and early relapse. International journal of clinical practice, 74(10), e13594. https://doi.org/10.1111/ijcp.1359
  7. Ng, D. L., Gan, G. G., Chai, C. S., Chee, K. H., Tan, K. L., Tan, S. B., & Bee, P. C. (2019). Comparing quality of life and treatment satisfaction between patients on warfarin and direct oral anticoagulants: a cross-sectional study. Patient preference and adherence, 13, 1363 1373. https://doi.org/10.2147/PPA.S204246
  8. Norashikin Saidon, Nur Adila Anuar, Chang Kian Meng, Ong Tee Chuan, Tan Sen Mui, Gan Gin Gin, Fadilah SAW, Hany Ariffin, Lin Hai Peng, Chan Lee Lee, Alan Teh, Bee Ping Chong. (2020) Evolution of Hematopoietic Stem Cell Transplant Programs in Malaysia. Blood cell therapy. doi.org/10.31547/bct-2019-01
  9. Gan GG, Hue YL. Anxiety, depression and quality of life of medical students in Malaysia. Med J Malaysia
  10. Issaragrisil, S., Cheng-Hwai, T., Bunworasate, U., Su-Peng, Y., Hung, L. Y., Tee, G. Y., Wahid, S. F., Chin, N. S., Puavilai, T., Gin, G. G., Piu, K. L., Wen-Li, H., Tsai-Yun, C., & Numbenjapon, T. (2017). Cyclophosphamide vs salvage chemotherapy plus G-CSF as chemo-mobilization in Asian patients undergoing autologous hematopoietic stem cell transplant. Bone marrow transplantation, 52(2), 299 300. https://doi.org/10.1038/bmt.2016.245
  11. Ten, L. C., Chin, Y. M., Tai, M. C., Chin, E. F. M., Lim, Y. Y., Suthandiram, S., ... & Gan, G. G. (2017). SNP variants associated with non-Hodgkin lymphoma (NHL) correlate with human leukocyte antigen (HLA) class II expression. Scientific Reports, 7.
  12. Bee, P. C., Sekaran, V., Ng, R. R., Kweh, T. Y., & Gan, G. G. (2017). The predictive value of early molecular response in chronic myeloid leukaemia patients treated with imatinib in a single real-world medical centre in a developing country. Singapore medical journal, 58(3), 150 154. https://doi.org/10.11622/smedj.2016063
  13. Cheong CS, Gan GG, Bee PC, Chen TM, Lim CC.(2016) PARVOVIRUS B19 ASSOCIATED HAEMOPHAGOCYTIC LYMPHOHISTIOCYTISIS IN HEREDITARY SPHEROCYTOSIS PATIENT: A CASE REPORT.JUMMEC19(2), 12-116
  14. DLC Ng, GG Gan, YC Leong.(2016) Quality of life among lymphoma survivors in a developing country. Supportive Care in Cancer, 24 (12): 5015-5023
  15. Gan GG, Hue YL, Sathar J. (2016) Factors affecting quality of life in adult patients with Thalassemia Major and Intermedia. Ann Acad Med Singapore, 45(11):520-523
  16. Gan, G. G., Leong, Y. C., Bee, P. C., Chin, E. F., Abdul Halim, H., Nadarajan, V. S., & Teh, A. K. (2016). Influence of genetic polymorphisms of cytokine genes in the outcome of HLA-matched allogeneic stem cell transplantation in a South East Asian population. Cytokine, 78, 55 61. https://doi.org/10.1016/j.cyto.2015.11.022
  17. Gan, G. G., Leong, Y. C., Bee, P. C., Chin, E., & Teh, A. K. (2015). Complementary and alternative medicine use in patients with hematological cancers in Malaysia. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 23(8), 2399 2406. https://doi.org/10.1007/s00520-015-2614-z
  18. Lim, Y. Y., Chin, Y. M., Tai, M. C., Fani, S., Chang, K. M., Ong, T. C., Bee, P. C., Gan, G. G., & Ng, C. C. (2015). Analysis of interleukin-10 promoter single nucleotide polymorphisms and risk of non-Hodgkin lymphoma in a Malaysian population. Leukemia & lymphoma, 56(1), 163 168. https://doi.org/10.3109/10428194.2014.907895
  19. Suthandiram, S., Gan, G. G., Mohd Zain, S., Bee, P. C., Lian, L. H., Chang, K. M., Ong, T. C., & Mohamed, Z. (2015). Genetic polymorphisms in the one-carbon metabolism pathway genes and susceptibility to non-Hodgkin lymphoma. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 36(3), 1819 1834. https://doi.org/10.1007/s13277-014-2785-0
  20. Gan, G. G., Subramaniam, R., Bee, P. C., Chin, E. F., Abdul-Halim, H., & Tai, M. C. (2014). Impact of inadequate doses of rituximab in the treatment of diffuse large B cell lymphoma in Malaysian patients. Asian Pacific journal of cancer prevention : APJCP, 15(4), 1703 1706. https://doi.org/10.7314/apjcp.2014.15.4.1703
  21. Suthandiram, S., Gan, G. G., Zain, S. M., Bee, P. C., Lian, L. H., Chang, K. M., Ong, T. C., & Mohamed, Z. (2014). Effect of polymorphisms within methotrexate pathway genes on methotrexate toxicity and plasma levels in adults with hematological malignancies. Pharmacogenomics, 15(11), 1479 1494. https://doi.org/10.2217/pgs.14.97
  22. Suthandiram, S., Gan, G. G., Zain, S. M., Haerian, B. S., Bee, P. C., Lian, L. H., Chang, K. M., Ong, T. C., & Mohamed, Z. (2014). Polymorphisms in methylenetetrahydrofolate reductase gene and risk of non-Hodgkin lymphoma in a multi-ethnic population. Journal of human genetics, 59(5), 280 287. https://doi.org/10.1038/jhg.2014.19
  23. Gan, G. G., Norfaizal, A. L., Bee, P. C., Chin, E. F., Habibah, A. H., & Goh, K. L. (2013). Helicobacter pylori infection in chronic immune thrombocytopenic purpura patients in Malaysia. The Medical journal of Malaysia, 68(3), 231 233
  24. Gan, G. G., Subramaniam, R., Lian, L. H., & Nadarajan, V. (2013). Ethnic variation in interleukin-6 -174 (g/c) polymorphism in the malaysian population. Balkan journal of medical genetics : BJMG, 16(2), 53 58. https://doi.org/10.2478/bjmg-2013-0032
  25. Razali, R. M., Bee, P. C., & Gan, G. G. (2013). Survey of willingness to accept chemotherapy among elderly Malaysian patients. Asian Pacific journal of cancer prevention : APJCP, 14(3), 2029 2032. https://doi.org/10.7314/apjcp.2013.14.3.2029
  26. Tan, R., Ng, K. P., Gan, G. G., & Na, S. L. (2013). Fusarium sp. infection in a patient with Acute Lymphoblastic Leukaemia. The Medical journal of Malaysia, 68(6), 479 480.
  27. Bee, P. C., Gan, G. G., Tai, Y. T., Haris, A. R., Chin, E., & Veera, S. N. (2012). An update on imatinib mesylate therapy in chronic myeloid leukaemia patients in a teaching hospital in Malaysia. Singapore medical journal, 53(1), 57 61
  28. im, W. F., Muniandi, L., George, E., Sathar, J., Teh, L. K., Gan, G. G., & Lai, M. I. (2012). -Haemoglobin stabilising protein expression is influenced by mean cell haemoglobin and HbF levels in HbE/ -thalassaemia individuals. Blood cells, molecules & diseases, 48(1), 17 21. https://doi.org/10.1016/j.bcmd.2011.10.002
  29. Bee, P. C., Gan, G. G., Sangkar, V. J., Haris, A. R., & Chin, E. (2011). Quality of life after haematopoietic stem cell transplantation in a multiracial population. The Medical journal of Malaysia, 66(5), 451 455.
  30. Choong, S. S., Rosmanizam, S., Ibrahim, K., Gan, G. G., & Ariffin, H. (2011). Development of an algorithm of satellite markers for monitoring chimerism status in post-allogeneic haematopoietic stem cell transplantation patients. International journal of laboratory hematology, 33(2), 182 186. https://doi.org/10.1111/j.1751-553X.2010.01264.x
  31. Gan, G. G., Phipps, M. E., Lee, M. M., Lu, L. S., Subramaniam, R. Y., Bee, P. C., & Chang, S. H. (2011). Contribution of VKORC1 and CYP2C9 polymorphisms in the interethnic variability of warfarin dose in Malaysian populations. Annals of hematology, 90(6), 635 641. https://doi.org/10.1007/s00277-010-1119-6
  32. Nadarajan, V. S., Phan, C. L., Ang, C. H., Liang, K. L., Gan, G. G., Bee, P. C., & Zakaria, Z. (2011). Identification of copy number alterations by array comparative genomic hybridization in patients with late chronic or accelerated phase chronic myeloid leukemia treated with imatinib mesylate. International journal of hematology, 93(4), 465 473. https://doi.org/10.1007/s12185-011-0796-9
  33. SAM Mukari, N Ramli, SAA Edrus, M Noordin, K Rahmat, LM Looi, D Ganesan, GG Gan, CT Tan. Central nervous system intravascular lymphoma in a Malaysian. Neurology Asia 2011; 16(1): 93-95
  34. Bee, P. C., Gan, G. G., Nadarajan, V. S., Latiff, N. A., & Menaka, N. (2010). A man with concomitant polycythaemia vera and chronic myeloid leukemia: the dynamics of the two disorders. International journal of hematology, 91(1), 136 139. https://doi.org/10.1007/s12185-009-0471-6
  35. Maha, A., Gan, G. G., & Koh, C. L. (2010). Phenotype and TCR-gamma gene rearrangements in a Malaysian cohort of T-cell leukaemia/lymphoma cases. Hematology (Amsterdam, Netherlands), 15(6), 382 390. https://doi.org/10.1179/102453310X12719010991902
  36. Fadzilah, M. N., Faizatul, L. J., Hasibah, M. S., Sam, I. C., Bador, M. K., Gan, G. G., & AbuBakar, S. (2009). Anaerobiospirillum succiniciproducens bacteraemia in a patient with acute lymphoblastic leukaemia. Journal of medical microbiology, 58(Pt 1), 142 143. https://doi.org/10.1099/jmm.0.004622-0
  37. Sthaneshwar, P., Nadarajan, V., Maniam, J. A., Nordin, N., & Gin Gin, G. (2009). Serum free light chains: diagnostic and prognostic value in multiple myeloma. Clinical chemistry and laboratory medicine, 47(9), 1101 1107. https://doi.org/10.1515/CCLM.2009.260
  38. Baskaran, N. D., Gan, G. G., & Adeeba, K. (2008). Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients. Annals of hematology, 87(7), 563 569. https://doi.org/10.1007/s00277-008-0487-7
  39. Bee, P. C., Gan, G. G., Sangkar, V. J., & Haris, A. R. (2008). Nephrotic syndrome in a patient with relapsed of chronic myeloid leukemia after peripheral blood stem cell transplantation. The Medical journal of Malaysia, 63(1), 71 72.
  40. Gan, G. G., Zakaria, Z., Sangkar, J. V., Haris, A. R., Bee, P. C., Chin, E., & Teh, A. (2008). Adult allogeneic haematopoietic stem cell transplantation: a single centre experience in Malaysia. The Medical journal of Malaysia, 63(4), 281 287.
  41. Gan, G., Teh, A., Chan, L., Cheong, S., Chang, K., & Ibrahim, H. (2008). Bone marrow and stem cell transplantation: Malaysian experience. Bone marrow transplantation, 42 Suppl 1, S103 S105. https://doi.org/10.1038/bmt.2008.129
  42. Peh, S. C., Gan, G. G., Lee, L. K., & Eow, G. I. (2008). Clinical relevance of CD10, BCL-6 and multiple myeloma-1 expression in diffuse large B-cell lymphomas in Malaysia. Pathology international, 58(9), 572 579. https://doi.org/10.1111/j.1440-1827.2008.02273.x
  43. Baskaran, N. D., Gan, G. G., Adeeba, K., & Sam, I. C. (2007). Bacteremia in patients with febrile neutropenia after chemotherapy at a university medical center in Malaysia. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 11(6), 513 517. https://doi.org/10.1016/j.ijid.2007.02.002
  44. PC Bee, GG Gan, AR Haris, Z Zakaria, Wan Ahmad WA.2007 Comparison of a portable device and standard Laboratory measured INR in the University Malaya Medical Centre. Asean Heart J;15:59-62
  45. Palasubramaniam, S., Karunakaran, R., Gin, G. G., Muniandy, S., & Parasakthi, N. (2007). Imipenem-resistance in Klebsiella pneumoniae in Malaysia due to loss of OmpK36 outer membrane protein coupled with AmpC hyperproduction. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 11(5), 472 474. https://doi.org/10.1016/j.ijid.2007.01.005
  46. Bee, P. C., Gan, G. G., Teh, A., & Haris, A. R. (2006). Imatinib mesylate in the treatment of chronic myeloid leukemia: a local experience. The Medical journal of Malaysia, 61(5), 547 552.
  47. Gan, G. G., Pasagna, J. F., Eow, G. I., & Nadarajan, V. S. (2007). Chronic neutrophilic leukaemia. Singapore medical journal, 48(3), e74 e76.
  48. Abdullah, B. J., Mohammad, N., Sangkar, J. V., Abd Aziz, Y. F., Gan, G. G., Goh, K. Y., & Benedict, I. (2005). Incidence of upper limb venous thrombosis associated with peripherally inserted central catheters (PICC). The British journal of radiology, 78(931), 596 600. https://doi.org/10.1259/bjr/32639616
  49. Gan, G. G., Leong, C. F., Sangkar, J. V., Teh, A., Goh, K. Y., & Cheong, S. K. (2005). The use of mycophenolate mofetil in treating patients with non responding aplastic anemia. The Medical journal of Malaysia, 60(3), 311 313
  50. Shia, A. K., Gan, G. G., Jairaman, S., & Peh, S. C. (2005). High frequency of germinal centre derivation in diffuse large B cell lymphoma from Asian patients. Journal of clinical pathology, 58(9), 962 967. https://doi.org/10.1136/jcp.2004.022624
  51. Bee, P. C., Gan, G. G., Sangkar, J. V., Teh, A., & Goh, K. Y. (2004). A case of T-cell acute lymphoblastic leukemia after treatment of acute promyelocytic leukemia. International journal of hematology, 79(4), 358 360. https://doi.org/10.1532/ijh97.a20304
  52. Gan, G. G., Eow, G. I., Teh, A., Ng, S. C., & Sangkar, J. V. (2004). Familial hemophagocytic lymphohistiocytosis in two brothers. The Medical journal of Malaysia, 59(1), 100 102.
  53. Gan, G. G., Phipps, M. E., Ku, C. S., Teh, A., & Sangkar, V. (2004). Genetic polymorphism of the CYP2C9 subfamily of 3 different races in warfarin maintenance dose. International journal of hematology, 80(3), 295 296. https://doi.org/10.1532/ijh97.a20401
  54. Gan, G. G., Teh, A., Goh, K. Y., Chong, H. T., & Pang, K. W. (2003). Racial background is a determinant factor in the maintenance dosage of warfarin. International journal of hematology, 78(1), 84 86. https://doi.org/10.1007/BF02983247
  55. Kim yen Goh, Gan Shiaw Sze @ Gan Gin Gin,JV Sangkar, R Puthashanan, M Norhafiza, Teh A. "Treatment of chronic myeloid leukemia patients with imatinib mesylate-the UMMC experience.", 2003, Med. J. Malaysia, Vol. 58, no. suppl, pg. 92-93
  56. Ng, K. P., Soo-Hoo, T. S., Na, S. L., Gan, G. G., Sangkar, J. V., & Teh, A. K. (2003). Scopulariopsis brevicaulis infection in a patient with acute myeloid leukemia. The Medical journal of Malaysia, 58(4), 608 612.
  57. Seng, K. C., Gin, G. G., Sangkar, J. V., & Phipps, M. E. (2003). Frequency of cytochrome P450 2C9 (CYP2C9) alleles in three ethnic groups in Malaysia. Asia-Pacific Journal of Molecular Biology and Biotechnology, 11(2), 83-91.
  58. Gan, G. G., Kamarulzaman, A., Goh, K. Y., Ng, K. P., Na, S. L., & Soo-Hoo, T. S. (2002). Non-sporulating Chrysosporium: an opportunistic fungal infection in a neutropenic patient. The Medical journal of Malaysia, 57(1), 118 122.
  59. Suat Cheng & Tai, Yan-Chin & Kim, Lian-Hua & Athinarayanan, Shaminie & Gan, Shiaw-Sze & Lin, Hai-Peng. (2002). The Pattern of Burkitt's Lymphoma in Malaysian Patients. Journal of Clinical and Experimental Hematopathology. 42. 67-73. 10.3960/jslrt.42.67.
Article in Proceeding
  1. Case series of AL amyloidosis in University Malaya Medical Centre, 17th Malaysian Society of Haematology Scientific Meeting
  2. Case series of HIV associated lymphoma treated in UMMC, 17th Malaysian Society of Haematology scientific meeting
  3. Early disease progression in diffuse large B cell lymphoma associated clinical features and prediction tool, 17th malaysian Society of Haematology scientific meeting
  4. Evolution of Haematopoietic stem cell transplant programs in Malaysia , 17th Malaysian Society of Haematology Scientific Meeting
  5. Impact of donor chimerisms monitroing following allogenic stem cell transplantation : single centre experience in Malaysia, 17th Malaysian Society of Haematology scientific meeting
  6. Incidence and risk factors associated with peripherally inserted central catheter related complications in adult hematological cancer patients. 17th Malaysian Society of Haematology scientific meeting
  7. Kim Huynh, Naomi Aoki, Kihyun Kim, Wee Joo Chng, Gin Gin Gan, Chang-Ki Min, Je-Jung Lee, Yeow Tee Goh, Cameron Wellard, Zoe McQuilten, Elizabeth M. Moore, Erica M. Wood, Andrew Spencer; The Asia-Pacific Myeloma and Related Diseases Registry: Preliminary Results of Real-World Treatment Patterns and Clinical Outcomes. Blood 2020; 136 (Supplement 1): 30 31. doi: https://doi.org/10.1182/blood-2020-136896
  8. Rehabilitation needs of lymphoma patients - in a single centre, 17th Malaysian Society of Haematology Scientific Meeting
  9. The effect of single session 30-minutes mindful breathing on fatigue reduction among hematology malignancy patients , 17th Malaysian Society of Haematology scientific meeting
  10. Treatment modalities and outcome of multiple meyloma patients in University malaya medical centre, 17th Malaysian Society of Haematology Scientific Meeting
  11. Type B lactic acidosis in mantile cell lymphoma, 17th Malaysian Society of Haematology Scientific Meeting
  12. Local prevalence of and survival outcome of bacterial infection within 100 days post allogenic stem cell transplantation: a single centre experience, 16th Malaysian Society of Haematology Scientific meeting
  13. Non-Hogkin Lymphoma in Malaysia: A single centre experience. 16th Malaysian Society of Haematology Scientific meeting
  14. Treatment outcome and PET/CT scan findings in Hodgkin lymphoma and diffuse large B cell lymphoma in a teaching hospital in Klang valley, 16th Malaysian Society of Haematology Scientific meeting
  15. Prevalence of anxiety and depression among caregivers of cancer patients in malaysia. 16th MSH annual scientific meeting
  16. Prognostic factors of disease relapsed/refractory in RCHOP treated Diffuse large B cell lymphoma patients , 15th MSH annual scientific meeting
  17. Successful pregnancy outcome in patients with paroxysmal nocturnal hemoglobinuria, 16th MSH annual scientific meeting
  18. HLA HAPLOIDENTICAL BONE MARROW TRANSPLANTATION IN HIGH RISK HEMATOLOGICAL MALIGNANCIES : A SINGLE CENTRE CASE SERIES. 13th MSH annual scientific meeting
  19. SEXUAL DYSFUNCTION AMONG FEMALE LYMPHOMA PATIENTS IN UNIVERSITY MALAYA MEDICAL CENTRE. 13th MSH annual scientific meeting
  20. 44.CL Wong, G Gerrad, ZA Norziha, NR Tumian, SK Cheong, CF Leong, PC Bee, GG Gan, J Sathar, B Ma, L Liang, L Foroni, T Aitman, M Laffan. JAK2 V617F mutation in combination of ASXL1, DNMT3, TET2, U2AF1 and RUNX1 variants is associated with severe clinical phenotypes in primary myelofibrosis. Haematologica 2015 ; 100 (suppl 1):531
  21. DLC Ng, GG Gan, YC Leong. Quality of life among lymphoma survivors in developing country. Annals of Oncology 2015; 26(suppl 9):85-92. Doi:10.1093/annonc/mdv526.20
  22. GG Gan, YC Leong, D Ng, PC Bee, E Chin, AKH Teh.Anxiety and depression in patients with haematological cancers in Malaysia.The XIIth Malaysian National Haematology Scientific Meeting 2015,
  23. GG Gan, DLC Ng, YC Leong. Quality of life in patients with haematological cancers at university Malaya Medical Center. The XIth Malaysian National Haematology Scientific Meeting 2014, Kuala Lumpur , Malaysia . April 2014,pg64
  24. GG Gan, HL Lee, PC Bee. E Chin, CG Ng. Complementary and alternative medicine use in patients with haematological malignancies in UMMC. The XIth Malaysian National Haematology Scientific Meeting 2014, Kuala Lumpur , Malaysia . April 2014, page 63
  25. Norashikin Saidon, PC Bee, GG Gan. Beliefs in iron chelation therapy among adult transfusion dependent thalassemia patients in University Malaya Medical Centre. The XIth Malaysian National Haematology Scientific Meeting 2014, Kuala Lumpur , Malaysia . April 2014
  26. Ethnic variation in Interleukin-6 -174G/C polymorphism in Malaysian Population Gan GG, Subramaniam R, Lian LH, Nadarajan VS
  27. Ethnic variation in Interleukin-6 -174G/C polymorphism in Malaysian Population Gan GG, Subramaniam R, Lian LH, Nadarajan VS
  28. The epidemiology of invasive fungal infection in patients with haematological diseases in a tertiary centre in Malaysia Ting SK, Gan GG Bee PC1 , Chin E , , Habibah MAH , Na SL, Ng KP ,
  29. GG Gan, Subramaniam R, Nadarajan V. Cytokine gene frequency in Malaysian population. 8th National haematology scientific meeting, April 2010; pg86
  30. GG Gan, Subramaniam R, Nadarajan VS, Haris AR, PC Bee, E Chin, Habibah AH. Cytokine gene polymorphism and acute graft versus host disease in allogeneic stem cell transplantation.First Asean Federation of Haematology and 8th National haematology scientific meeting, April 2010,pg 84
  31. H Abdul Halim, GG Gan , KP Ng, MHF Abdul Rahman, E Chin, N Abdul Latiff, WC Su,MC Mok. Retrospective study of positive fungal blood cultures in University Malaya Medical centre: clinical relevance and outcome revisited. First Asean Federation of Haematology and 8th National haematology scientific meeting, April 2010,pg 86
  32. Nadarajah VS, Subramanian R, GG Gan. The IL-12 '3UTR (-1188A/C) polymorphism is associated with survival outcome of hematopoeitic stem cell transplants. First Asean Federation of Haematology and 8th National Hameatology scientific meeting, pg 102
  33. Norfaizal L, GG Gan, Bee PC, Haris AR, E Chin, Habibah AH. A pilot study to look at the effect of helicobacter pylori eradication in adults with immune thrombocytopenia purpura at UMMC. First Asean Federation of Haematology and 8th National haematology scientific meeting, April 2010,p83
  34. Norfaizal L, GG Gan, Bee PC, Haris AR, E Chin, Habibah AH. Autologous peripheral blood stem cell harvesting: factors that influence the yield of stem cells. First Asean Federation of Haematology and 8th National haematology scientific meeting, April 2010, pg 85
  35. PC Bee, GG Gan Ting TY, Haris AR, E Chin, Habibah AH, Nadarajan VS. An Update on Imatinib Mesylate Therapy in Chronic Myeloid Leukaemia Patients in a Teaching Hospital in Malaysia. First Asean federation of Haematology and 8th National haematology ,pg 80 scientific meeting, April 2010,pg 80
  36. PC Bee, GG Gan, Haris AR, E Chin. Appetite loss is an independent adverse factor for poorer Quality of Life after Haematopoietic Stem Cell Transplantation in a Teaching Hospital in Malaysia. First Asean Federation of Haematology and 8th National haematology scientific meeting, April 2010, pg81
  37. PC Bee, GG Gan, Haris AR, E Chin. The Influence of Ethnicity upon Quality of Life after Haematopoietic Stem Cell Transplantation in a Teaching Hospital in Malaysia. First Asean Federation of Haematology and 8th National haematology scientific meeting, April 2010
  38. Phan CL, Ang CH, Liang KL, Gan GG, Zubaidah Z, Nadarajah VS. Identification of unbalanced genomic abberations by array CGH in chronic myeloid leukemia patients with suboptimal response to imatinib treatment. First Asean Federation of Haematology and 8th National haematology scientific meeting,p121
  39. 17.E Chin, GG Gan, PC Bee, Haris Rahman. A retrospective study of CHOP-like chemotherapy plus Rituximab compared with CHOP-like chemotherapy alone in patients with diffuse large B cell Lymphoma in UMMC. 7th National Haematology scientific Meeting., April 2008, p68
  40. GG Gan, ME Phipps, TA Jinam, RH Abdul Rahman, PC Bee. VKORC1 gene polymorphism is responsible for interethnic variation of warfarin dose. 7th National Haematology scientific Meeting., April 2008, p61
  41. PC Bee, GG Gan, Jv Sangkar. Haris Rahman, E Chin. Quality of Life after stem cell transplantation. 7th National Haematology scientific Meeting., April 2008, p68
  42. PC Bee, Haris AR, JV Sangkar, E Chin, GG Gan. A rare presentation of multiple myeloma: multiple cranial nerves lesions secondary to intracranial plasmacytoma. 7th National Haematology scientific Meeting., April 2008, p69
  43. PC Bee, L Ng, Sasheela, GG Gan. Infection in febrile neutropenia patients: antibiotic usage , microbiology and antibiotic resistance pattern. 7th National Haematology scientific Meeting., April 2008, p67
  44. 16.Rafidah Mohamada, Gan Gin Ginb, Veera S Nadarajanc.Dendritic cells and cytokine levels as predictors of acute graft-versus-host disease in allogeneic stem cell transplantation. 24th World Congress of Pathology and Laboratory Medicine 2007. 20- 24th August
  45. Peh SC, Gan GG, Lee LK and Eow GI. The Antigen Expressions of BCL-2, BCL-6, CD10, CD138 and MUM-1 in Diffuse Large B-Cell Lymphomas: A Cohort Study. In, Proceedings: 24th World Congress of Pathology and Laboratory Medicine, Sunway Pyramid Convention Centre, Petaling Jaya, Selangor, 20 24 August 2007. Abstract published in The Malaysian Journal of Pathology 2007; 29(Supp A): 170.
  46. Zakaria MZ, Gan GG, Rahman HF, Bee PC. Teicoplanin- induced aplastic anemia. 6th Malaysian National Haematology Scientific Meeting, April 2006. p63
  47. Zakaria MZ, Gan GG, Rahman HF, Bee PC. Treatment of refractory idiopathic thrombocytopenia purpura with the anti-CD20 monoclonal antibody Rituximab. 6th Malaysian National Haematology Scientific Meeting, April 2006. p95
  48. GG Gan CC Kam, SC Peh, JV Sangkar. A Clinical report of Diffuse Large B cell Lymphoma in University Malaya Medical Centre. 5th Malaysian National Haematology Scientific Meeting, April 2004. p73
  49. GG Gan, S Wong, A Teh, KY Goh, JV Sangkar. Adult Allogeneic Hematopoetic Stem Cell Transplantation-UMMC experience. 5th Malaysian National Haematology Scientific Meeting, April 2004 p89
  50. JV Sangkar, Kamarulzaman A, GG Gan, A Teh. Case Report: Candida Parapsilosis Cellulitis. . 5th Malaysian National Haematology Scientific Meeting, April 2004 p83
  51. SS Gan, CF Leong, VS Jaganathan, KY Goh, AKH Teh, SK Cheong, SC Ng. Mycophenolate mofetil and aplastic anemia. 8Th Annual Congress of the European Hematology Association, June 2003
  52. SS Gan, SC Ng , AKH Teh, KY Goh, VS Jaganathan, Low dose thalidomide as a treatment for relapsed/refractory multiple myeloma. 8Th Annual Congress of the European Hematology Association, June 2003
  53. Gan GG, Ng SC, Teh A, Eow GI. Drug induced agranulocytosis treated with hematopoietic growth factor A report of 11 patients. 42nd Annual Meeting of American Society of Hematology, San Francisco, California. Blood 2000; 96(11); p154b
  54. Goh KY, Teh A, Gan GG . BFM B cell protocol as salvage chemotherapy for relapsed and refractory high grade Non-Hodgkin Lymphoma B cell type. 28th World Congress of the International Society of Hematology, Toronto, Canada, August 2000. p91
  55. Ng SC, Gan GG. The development of autoimmune disease in immune thrombocytopenia purpura patients a long term follow up of 72 Asian patients. 42nd Annual meeting of American Society of Hematology. San Francisco, California, Blood 2000; 96 (11): p68b

RESEARCH PROJECT


National
  1. 2019 - 2023, Fundamental Research Grant Scheme (FRGS)
    Elucidating The Role Of Gut Microbiome In Relation To The Outcomes Of Patients With Acute Leukemias: A Malaysian Perspective ( Principal Investigator(PI))
  2. 2019 - 2023, Fundamental Research Grant Scheme (FRGS)
    Transcriptional Control Of Runx1 In Plasma Cell Antibody Secretion And Its Association With Malignant Multiple Myeloma ( Co-Researcher)
  3. 2020 - 2023, Partnership Grant
    The Epidemiology Of Invasive Fungal Infections In Patients With Haematological Cancers And Its Risk Factors ( Principal Investigator(PI))
  4. 2019 - 2020, Partnership Grant
    ELUCIDATING TRANSCRIPTION FACTORS INVOLVED IN ANTIBODY-PRODUCING PLASMA CELLS ( Principal Investigator(PI))
  5. 2017 - 2019, Bantuan Kecil Penyelidikan (BKP)
    To determine the frequency of CYP2C19 genotypes in patients with coronary artery disease treated at our local centre and correlate to the clinical outcome of these patients. ( Co-Researcher)
  6. 2006 - 2010, MOSTI-Science Fund
    ASSOCIATION STUDY OF SINGLE NUCLEOTIDE POLYMORPHISMS IN SELECTED CANDIDATE GENES AND NON-HODGKIN\'S LYMPHOMA IN THE MALAYSIAN POPULATIONS ( Principal Investigator(PI))
  7. 2009 - 2010, Geran Penyelidikan Universiti Malaya (UMRG)
    A PILOT STUDY TO DETERMINE IF ASSOCIATION OF CYTOKINE GENE POLYMORPHISM INFLUENCE THE RISK OF GRAFT VERSUS HOST DISEASE IN ALLOGENEIC HEMOTOPOIETIC STEM CELL TRANSPLANTATION ( Principal Investigator(PI))
  8. 2007 - 2008, 7
    GENETIC POLYMORPHISMS OF VITAMIN K EPOXIDE REDUCTASE (VKORC), ASSOCIATED GENES AND WARFARIN DOSE VARIABILITY IN MALAYSIAN POPULATION ( Principal Investigator(PI))
  9. 2017 - 2020, Bantuan Kecil Penyelidikan (BKP)
    Frequency of CYP2C9 genotypes in patient with coronary artery disease treated at our local centre and correlate with clinical outcomes ( Consultant)
  10. 2016 - 2018, Private Funding
    quality of life of family caregivers of cancer patients in Malaysia ( Principal Investigator(PI))
  11. 2011 - 2015, High Impact Research (HIR)
    Molecular Genetic: Project 8. Genome Organization in Diseases: from Mutations to Structural Variations and Epigenetics ( Consultant)
  12. 2012 - 2014, Geran Penyelidikan Universiti Malaya (UMRG)
    polymorphisms in DNA repair genes and risk of Non Hodgkin lymphoma ( Consultant)
  13. 2011 - 2012, Geran Penyelidikan Universiti Malaya (UMRG)
    Interleukin 6 and 12 polymorphism is associate with poor outcome in haematopoeitic stem cell transplantation. ( Principal Investigator(PI))
  14. 2009 - 2011
    A Randomized, Double-Blind, Placebo-Controlled, Phase II study To Evaluate Efficacy And Safety of Deferasirox In Non-Transfusion-Dependent Thalassemia Patients With Iron Overload (THALASSA) ( Consultant)
  15. 2009 - 2010, Geran Penyelidikan Universiti Malaya (UMRG)
    A pilot study to determine if association of cytokine gene polymorphism influence the risk of graft versus host disease in allogeneic hematopoeitic stem cell transplantation ( Principal Investigator(PI))
  16. 2008 - 2010, ScienceFund
    SERIAL IDENTIFICATION OF UNBALANCED GENOMIC ABERRATIONS BY ARRAY CGH IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA ON IMATINIB TREATMENT : CORRELATION WITH CORRESPONDING GENE EXPRESSION, MIRNA AND TREATMENT RESPONSE ( Consultant)
  17. 2006 - 2008, ScienceFund
    Association study of single nucleotide polymorphisms in selected candidate genes in NonHodgkin lymphoma in Malaysian population ( Principal Investigator(PI))
  18. 2007 - 2008, Fundamental Research Grant Scheme (FRGS)
    Genetic polymorphisms of vitamin K epoxide reductase (VKORC), associated genes and warfarin dose variability in Malaysian Population. ( Principal Investigator(PI))
  19. 2004 - 2005, Short Term Research Fund (Vote F)(PJP)
    helicobacter pylori and immune thrombocytopenia purpura ( Principal Investigator(PI))
  20. 2003 - 2004, Fundamental Research Grant Scheme (FRGS)
    clinical relevance of genetic polymorphism in human CYP2C9 subfamily and racial backgrounds in warfarin maintenance dose in Malaysia ( Principal Investigator(PI))
Private
  1. 2021 - 2024, Private Funding
    Assessing Immune Responses To Covid-19 Vaccination Among Patients With Chronic Myeloid Leukemia- Phase 1 ( Principal Investigator(PI))
  2. 2020 - 2023, Private Funding
    Defining The Incidence And Potentials Risk Factors Of Invasive Fungal Infections In Patients With Hematological Malignancies And A Study On Antifungal Resistance ( Principal Investigator(PI))
  3. 2020 - 2020, Private Funding
    Role of RUNX1 in Plasma Cell Differentation in Multiple Myeloma Patients ( Principal Investigator(PI))
  4. 2018 - 2019, Private Funding
    Role of Runx1 in plasma cell differentiation in multiple myeloma patients ( Principal Investigator(PI))
International
  1. 2019 - 2022, International Funding
    Asia-Pacific Myeloma and Related Diseases Registry (APAC MRDR) ( Principal Investigator(PI))
  2. 2020 - 2022, International Funding
    A randomized, double-blind, placebo-controlled phase III multi-center study of azacitidine with or without MBG453 for the treatment of patients with intermediate, high or very high risk myelodysplastic syndrome (MDS) as per IPSS-R, or Chronic Myelomonocytic Leukemia-2 (CMML-2) ( Principal Investigator(PI))
  3. 2021 - 2022, International Funding
    FREESIA ( Consultant)
  4. 2019 - 2021, International Funding
    Randomized Phase 3 study of Pomalidomide-Cyclophosphamide-Dexamethasone (PCD) versus Pomalidomide-Dexamethasone (PD) in relapse or refractory myeloma. An AMN study ( Consultant)
  5. 2015 - 2019, Private Funding
    A randomized, double-blind, phase III study comparing Biosimilar Rituximab (RTXM83) plus CHOP chemotherapy versus Reference Rituximab plus CHOP (R-CHOP) in patients with Diffuse Large B-Cell Lymphoma (DLBCL) given as first line RTXM83-AC-01-11 ( Principal Investigator(PI))
  6. 2014 - 2019, International Funding
    A single arm study of brentuximab vedotin in patients with relapsed and refractory Hodgkin lymphoma who are not suitable for stem cell transplantation or multiagent chemotherapy ( Principal Investigator(PI))
  7. 2017 - 2019, Private Funding
    microRNA expression (genetic testing) for early detection of diffuse large b cell lymphoma recurrences ( Consultant)
  8. 2015 - 2018, International Funding
    Global Anticoagulant Registry in the FIELD observing treatment and outcomes in patients with treated acute Venous Thromboembolic Events in the real world 2015- current ( Consultant)
  9. 2014 - 2015, International Funding
    A phase 3 randomized study of the efficacy and safety of posaconazole versus voriconazole for the treatment of invasive aspergillosis in adults and adolescents. ( Principal Investigator(PI))
  10. 2014 - 2015, International Funding
    A Randomized, Multicenter, Open-Label, Phase 3 Study of the Bruton s Tyrosine Kinase (BTK) Inhibitor PCI-32765 (Ibrutinib) versus Rituximab in Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma ( Principal Investigator(PI))
  11. 2013 - 2014, International Funding
    a retrospective analysis of safety,efficacy and cost of chemo-mobilization for patients planned to udnergo autologous-HCT ( Consultant)
  12. 2008 - 2013, Johnson & Johnson Pharmaceutical Research & Development
    A RANDOMISED, OPEN-LABEL, MULTICENTRE PHASE 3 STUDY OF THE COMBINATION OF RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, VELCADE AND PREDNISONE (VcR-CAP) OR RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE AND PREDNISONE (R-CHOP) IN PATIENTS WITH NEWLY DIAGNOSED MANTLE CELL LYMPHOMA WHO ARE NOT ELIGIBLE FOR A BONE MARROW TRANSPLANT. ( Principal Investigator(PI))
  13. 2007 - 2010, basilea
    a phase III double blinded randomised study to evaluate the safety and efficacy of BAL8557 versus voriconazole for primary treatment of invasive fungal disease caused by aspergillosis species or other filamentous fungi ( Principal Investigator(PI))
  14. 2008 - 2010, Merck
    an international , multicenter randomised double blindstudy of vorinostat (MK0683) or placebo in combination with bortezomib in patients with multiple myeloma ( MK0683-088) ( Consultant)
  15. 2006 - 2008, Novartis
    An open-label, multicenter, expanded access study of oral AMN 107 in adult patients with Imatinib (Glivec /Gleevec ) - resistant or - intolerant chronic myeloid leukemia in blast crisis, accelerated phase or chronic phase ( Principal Investigator(PI))

CONSULTANCY PROJECT


  • Asia Pacific Leukemia Consortium (Aplc), Asia Pacific Leukemia Consortium (APLC), Professional Consultant (Ir., Ar., Sr., Ts., dsbnya)
    12 Nov 2021 - 31 Dec 2025 (International)
  • City Cancer Challenge, City Cancer Challenge Foundation, National Cancer Society, MBPJ, MBSJ,MBSA, Professional Consultant (Ir., Ar., Sr., Ts., dsbnya)
    21 Nov 2021 - 30 Apr 2023 (National)
  • Clinical Guidelines On Covid-19 Vaccination in Malaysia , Second Edition, Ministry of Health , Professional Consultant (Ir., Ar., Sr., Ts., dsbnya)
    01 Apr 2021 - 30 Apr 2021 (National)
  • Iclusig Asia Advisory Board Meeting, steward cross, Professional Consultant (Ir., Ar., Sr., Ts., dsbnya)
    17 Aug 2019 - 17 Aug 2019 (International)
  • 2019 Hematology Advisory Board: Targeted Treatment for Aml, iqvia, Professional Consultant (Ir., Ar., Sr., Ts., dsbnya)
    02 Feb 2019 - 02 Feb 2019 (International)
  • Amgen Multiple Myeloma Advisory Board, Amgen, Professional Consultant (Ir., Ar., Sr., Ts., dsbnya)
    25 Jan 2019 - 25 Jan 2019 (National)
  • Review Standard for Cord Blood Banking and Transplantation, ministry of health
    01 Dec 2015 - 01 Dec 2015 (National)
  • National Antibiotic Guideline 2014, KKM
    01 Sep 2014 - 01 Sep 2015 (National)
  • Chronic Myeloid Leukaemia -Clinical Practice Guidelines, Malaysian Society of Haematology
    01 Feb 2015 - 01 Feb 2015 (National)

PAPER PRESENTED


INVITED SPEAKER
  1. Overview of invasive fungal infections in immunocompromised patients , Molecular and Non-Molecular Diagnostic of Invasive Fungal Infections Workshop 2022, Faculty of Medicine, University of Malaya  (University) (13 Sep 2022 - 13 Sep 2022)
  2. CAR-T cell therapy, Masterclass in Systemic Cancer Therapy (MSCT) 2022, University Malaya (National) (31 Jul 2022 - 31 Jul 2022)
  3. Prognostic assessment tools in MDS and CMML for treatment decisions , MDS preceptorship programme 2021, the University of Hong Kong, Hong Kong University (International) (14 Sep 2021 - 14 Sep 2021)
  4. CAR T cell therapy , Masterclass in Systemic Cancer Therapy 2021, Department of Oncology,UM and Malaysian Society of Oncology (National) (12 Sep 2021 - 12 Sep 2021)
  5. immunology disorders in hematology ; recent updates, Immunology seminar2021: recent updates in experimental and clinical immunology , UM, department of microbiology  (University) (01 Apr 2021 - 01 Apr 2021)
  6. COvid-19 vaccination in blood cancer patients, UMMC-TAC public forum - ask the expert on COvid-19 vaccination in cancer patients , UM, UMCRI  (University) (21 Feb 2021 - 21 Feb 2021)
  7. CAR T cell therapy, Masterclass in Systemic Cancer Therapy 2020 (MSCT2020), UM and MOS (National) (11 Sep 2020 - 12 Sep 2020)
  8. Treatment paradigm of invasive aspergillosis, MALAYSIA ISAVUCONAZOLE ADVISORY BOARD MEETING, Pfizer (Industry/company) (05 Sep 2020 - 05 Sep 2020)
  9. Overview of Follicular lymphoma , Follicular Lymphoma Education Webinar , Roche (Industry/company) (25 Jul 2020 - 25 Jul 2020)
  10. Infections post hematopoietic stem cell transplantation, 5th ASEAN Federation of Hematology (AFH)5th ISMI-HOTTI (International Scientific Meeting on Hematology, Oncology, Thrombosis and Transplantation/ Transfusion in Indonesia, the 2019 SEAHEF (Southeast Asian Hematology Forum) and the 2019 SEAMOF (Southeast Asian Medical Oncology Forum), Indonesian Society of Hematology and Transfusion Medicine (ISHTM) (International) (02 Nov 2019 - 03 Nov 2019)
  11. A literature review on CML in SEA - treatment choices and challenges?, 5th ASEAN Federation of Hematology (AFH), Indonesian Society of Hematology and Transfusion Medicine (ISHTM) (International) (02 Nov 2019 - 03 Nov 2019)
  12. infections post transplant, 5th Asean Federation of Haematology, ISMUI_HOTTI (International) (01 Nov 2019 - 03 Nov 2019)
  13. Chronic Myeloid leukemia- challenges, 5th AFH and ISMI HOTTI , ISMI_HOTTTI AFH (International) (01 Nov 2019 - 03 Nov 2019)
  14. CAR-T cell therapy, IMMUNO-ONCOLOGY SYMPOSIUM IN CONJUNCTION WITH WORLD CANCER RESEARCH DAY", UMCRI (University) (24 Sep 2019 - 24 Sep 2019)
  15. Car T cells , immuno-concology in conjunction with world cancer day , UM cancer institute (University) (24 Sep 2019 - 24 Sep 2019)
  16. Infection complication post HSCT, Hospital Ampang 2019 Transplant Update, Postgraduate Society of Haematology Malaysian (PoSH), (Government Sector/public Institution) (26 Jul 2019 - 27 Jul 2019)
  17. Discussions on PBM and impact on Clinical Practice, patient blood management , UMMC (Others) (01 Jul 2019 - 01 Jul 2019)
  18. MGUS: its clinical significance, 16th MSH Annual Scientific Meeting, Malaysian Society of Haematology (National) (18 Apr 2019 - 20 Apr 2019)
  19. MGUS;its clinical significance, malaysian society of haematology , MSH (National) (11 Apr 2019 - 13 Apr 2019)
  20. stem cell transplantation - its role in non haematological diseases and malignancies, 52nd Malaysia Singapore Congress of medicine , Academy of Medicine Malaysia, Academy of Medicine Singapore, Hong Kong Academy of Medicine (International) (27 Jul 2018 - 29 Jul 2018)
  21. mangaement of relapsed refractory DLBCL, Malaysian Society of Haematology Annual Scientific Meeting , Malaysian Society of Haematology (National) (19 Apr 2018 - 21 Apr 2018)
  22. high dose chemotherapy and stem cell rescue, MAsterclass in systemic chemotherapy , malaysian Society of oncology and University Malaya (University) (09 Mar 2018 - 10 Mar 2018)
  23. updates on managemnt of DLBCL, updates on haematological neoplasm , UM and MSH  (National) (09 Dec 2017 - 09 Dec 2017)
  24. updates on management of diffuse large B cell lymphoma , updates on heamatological neoplasm seminar, FOM and MSH  (National) (09 Dec 2017 - 09 Dec 2017)
  25. haematopoietic stem cell ; now and beyond, national stem cell seminar, MSCRT, UPM and NSCERT (National) (10 Oct 2017 - 10 Oct 2017)
  26. high dose chemotherapy , mastercalss on systemic cancer therapy, MOS, UMMC (National) (04 Mar 2017 - 05 Mar 2017)
  27. Acute leukemia in Malaysia, 13th MSH annual scientific meeting , MSH (National) (14 Apr 2016 - 16 Apr 2016)
  28. how i treat low grade lymphoma , klang-ampang national hematology update , KKM  (National) (31 Oct 2015)
  29. how i treat DLBCL-local perspective , Meet the expert session , roche (National) (11 Jul 2015)
  30. role of reduced intensity conditioning regimen for allogeneic stem cell transplantation, art of hematology, MSH, SSH and sanofi  (National) (23 Nov 2013 - 25 Nov 2013)
  31. the approach toa dult patients with thrombocytopenia , saturday teach in on hematology , academy of medicine, malaysia (National) (12 May 2012)
  32. management of MDs in the era of novel agents, the 9th Malaysian national haematology scientific meeting , Malaysian soceity of haematology (National) (30 Apr 2011)
  33. approach to haematology oncology emergencies, saturday teach in- haematology, academy of medicine (National) (08 Jan 2011 - 08 Jan 2011)
  34. genetic polymorphism and its impact on drug therapy, the 8th national haematology scientific meeting, malaysian society if haematology (National) (24 Apr 2010 - 26 Apr 2010)
  35. is mesenchymal stem cells immunosuppressive?lesson learned from GVHD, advances in stem cell therapy (University) (13 Dec 2009)
  36. early complication of haematopoeitic stem cell transplantation, Ampang Hospital update- ABC of transplantation, ampang hospital haematology department (National) (15 Aug 2009)
  37. diagnosis and treatment of invasive fungal disease in immunocompromsied patients, Malaysian Thoracic Society , MTS (National) (25 Jul 2009)
  38. novel therapy for relapsed/refractory multiple myeloma, multiple myeloma (Others) (16 May 2009)
  39. epigenetics in cancer, MDS talk  (Others) (17 Mar 2009)
  40. haematopoeitic stem cell transplantation in Malaysia, International Congress on bone marrow and stem cell transplantation (International) (13 Nov 2007 - 15 Nov 2007)
  41. managing the transfusion dependent patients, transfusion course (Others) (12 Mar 2007 - 14 Mar 2007)
  42. emerging treatment options of myelodysplastic syndrome, 6th natioanl scientific meeting of malaysian society of haematology (National) (22 Apr 2006 - 24 Apr 2006)
  43. transfusion support in neutropenic and immunocompromised, transfusion course (Others) (28 Mar 2006 - 30 Mar 2006)
  44. managing difficult mobiliser, stem cell manipulation-durrent practice and expectations, transfusion medicine course (University) (28 Mar 2005 - 01 Apr 2005)
EVENT ORGANISER
  1. scientific chair , 17th Malaysian Society of Haematology annual Scientific Meeting , Malaysian Society of Haematology (National) (10 Sep 2020 - 12 Sep 2020)
  2. updates , updates om haematology neoplasm, MSH and UM (National) (16 Nov 2019 - 16 Nov 2019)
  3. updates in haematology neoplasm, haematology neoplasm update, UM and MSH  (National) (16 Nov 2019 - 16 Nov 2019)
  4. updates on haematological neoplasms, updates on haematological neoplasms , Faculty of Medicine, Department of Medicine, Department of Pathology, Malaysian Society of Haematology (National) (03 Nov 2018 - 03 Nov 2018)
  5. updates on haematoloigcal neoplasm workshop , updates on haematoloigcal neoplasm workshop , UM, MSH (National) (09 Dec 2017 - 09 Dec 2017)
  6. Clinical transfusion workshop , clinical transfusion workshop , department of medicine, department transfusion medicine , malaysian society of hematology  (National) (21 Aug 2015 - 22 Aug 2015)
  7. organising chairperson, the XI national scientific meeting of Malaysian Society of Haematology , malaysian society of haematology  (National) (04 Apr 2014 - 06 Apr 2014)
POSTER PRESENTER
  1. IMPACT OF DONOR CHIMERISMS MONITORING FOLLOWING ALLOGENIC STEM CELL TRANSPLANTATION, APBMT , APBMT  (International) (28 Sep 2020 - 01 Oct 2020)
  2. PERIPHERALLY-INSERTED CENTRAL VENOUS CATHETER- RELATED COMPLICATIONS IN ADULT PATIENTS WITH HEMATOLOGICAL MALIGNANCY, 17th national scientific meeting Malaysian society of hematology , MSH (National) (17 Sep 2020 - 19 Sep 2020)
  3. A RETROSPECTIVE STUDY ON ANTIPHOSPHOLIPID SYNDROME IN UNIVERSITY OF MALAYA MEDICAL CENTRE FROM 2010-2018, 17th National Scientific Meeting Malaysian Society of Haematology, Malaysian Society of Haematology (National) (17 Sep 2020 - 19 Sep 2020)
  4. PRETREATMENT CLINICAL FACTORS PREDICTING REFRACTORINESS TO R-CHOP THERAPY IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA DISEASE, 17th National Scientific Meeting of Malaysian Society of Haematology , Malaysian Society of Haematology (National) (17 Sep 2020 - 19 Sep 2020)
  5. TREATMENT MODALITIES AND OUTCOME OF MULTIPLE MYELOMA PATIENTS IN UNIVERSITY MALAYA MEDICAL CENTER, 17th National Scientitic meeting MSH , Malaysian Society of Haematology (National) (17 Sep 2020 - 19 Sep 2020)
  6. Rehabilitation Needs in Lymphoma Patients a single centre experience, 17th National Scientific Meeting of Malaysian Society of Haematology, Malaysian Society of Haematology (National) (17 Sep 2020 - 19 Sep 2020)
  7. CASE SERIES OF HIV ASSOCIATED LYMPHOMA TREATED IN UMMC, 17th national scientific meeting MSH , Malaysian Society of Haematology (National) (17 Sep 2020 - 19 Sep 2020)
  8. JAK2V617F MUTATION IN MDS/MPN UNCLASSIFIABLE ASSOCIATED WITH EXTRAMEDULLARY HAEMATOPOIESIS A CASE REPORT, 17th National Scientific Meeting MSH, Malaysian Society of haematology (National) (17 Sep 2020 - 19 Sep 2020)
  9. CASE SERIES OF AL AMYLOIDOSIS IN UNIVERSITY OF MALAYA MEDICAL CENTER, 17th National Scientific Meeting MSH , Malaysian Society Haematology (National) (17 Sep 2020 - 19 Sep 2020)
  10. EPIDEMIOLOGY REVIEW OF LYMPHOMA IN A SINGLE INSTITUTION IN MALAYSIA, ICML-15, International Conference on Malignant Lymphoma (International) (18 Jun 2019 - 22 Jun 2019)
  11. Local Prevalence and Survival Outcome of Bacterial Infection Within 100 Days Post Allogenic HSCT: A Single Centre Experience, 16th National Scientific meeting , Malaysian Society of haematology (National) (11 Apr 2019 - 13 Apr 2019)
  12. TREATMENT OUTCOME AND PET/CT FINDINGS OF HODGKIN S LYMPHOMA AND DIFFUSE LARGE B CELL LYMPHOMA PATIENTS IN A TEACHING HOSPITAL IN KLANG VALLEY, 16th National Scientific Meeting , Malaysian Society of Haematology (National) (11 Apr 2019 - 13 Apr 2019)
  13. SEXUAL DYSFUNCTION AMONG FEMALE LYMPHOMA PATIENTS IN UNIVERSITY MALAYA MEDICAL CENTRE, 13th MSH annual scientific meeting, Malaysian Society of Haematology (National) (15 Apr 2016 - 16 Apr 2016)
  14. Cytokine gene polymorphism and acute graft versus host disease in allogeneic stem cell transplantation., 8th National haematology scientific meeting (23 Apr 2010)
  15. Autologous peripheral blood stem cell harvesting: factors that influence the yield of stem cells, First Asean Federation of Haematology and 8th National haematology scientific meeting, (23 Apr 2010)
  16. identification of unbalanced genomic abberations by array CGH in chronic myeloid leukemia patients with suboptimal response to imatinib treatment, First Asean Federation of Haematology and 8th National haematology scientific meeting, (23 Apr 2010)
  17. The IL-12 '3UTR (-1188A/C) polymorphism is associated with survival outcome of hematopoeitic stem cell transplants, first Asean Federation of Haematology and 8th National haematology scientific meeting, (23 Apr 2010)
  18. Cytokine gene frequency in Malaysian population., 8th National haematology scientific meeting (23 Apr 2010)
  19. An Update on Imatinib Mesylate Therapy in Chronic Myeloid Leukaemia Patients in a Teaching Hospital in Malaysia, 8th National haematology scientific meeting, (23 Apr 2010)
  20. Appetite loss is an independent adverse factor for poorer Quality of Life after Haematopoietic Stem Cell Transplantation in a Teaching Hospital in Malaysia., 8th National haematology scientific meeting, (23 Apr 2010)
  21. The Influence of Ethnicity upon Quality of Life after Haematopoietic Stem Cell Transplantation in a Teaching Hospital in Malaysia., 8th National haematology scientific meeting, April 2010 (23 Apr 2010)
  22. Retrospective study of positive fungal blood cultures in University Malaya Medical centre: clinical relevance and outcome revisited., 8th National haematology scientific meeting, April 2010 (23 Apr 2010)
  23. Quality of Life after stem cell transplantation. , 7th National Haematology scientific Meeting (National) (25 Apr 2008)
  24. rare presentation of multiple myeloma: multiple cranial nerves lesions secondary to intracranial plasmacytoma, National Haematology scientific Meeting. (National) (25 Apr 2008)
  25. PC Bee, L Ng, Sasheela, GG Gan. Infection in febrile neutropenia patients: antibiotic usage, microbiology and antibiotic resistance pattern. April 2008, p67, 7th National Haematology scientific Meeting (National) (25 Apr 2008)
  26. retrospective study of CHOP-like chemotherapy plus Rituximab compared with CHOP-like chemotherapy alone in patients with diffuse large B cell Lymphoma in UMMC., 7th National Haematology scientific Meeting., April 2008 (25 Apr 2008)
  27. VKORC1 gene polymorphism is responsible for interethnic variation of warfarin dose. 7th National Haematology scientific Meeting, 7th National Haematology scientific Meeting (25 Apr 2008)
  28. A retrospective study of CHOP-like chemotherapy plus Rituximab compared with CHOP-like chemotherapy alone in patients with diffuse large B cell Lymphoma in UMMC. , 7th National Haematology scientific Meeting (National) (25 Apr 2008)
  29. Infection in febrile neutropenia patients: antibiotic usage , microbiology and antibiotic resistance pattern., 7th National Haematology scientific Meeting., (18 Apr 2008)
  30. A rare presentation of multiple myeloma: multiple cranial nerves lesions secondary to intracranial plasmacytoma., 7th National Haematology scientific Meeting (18 Apr 2008)
  31. Quality of Life after stem cell transplantation, 7th National Haematology scientific Meeting (18 Apr 2008)
  32. The Antigen Expressions of BCL-2, BCL-6, CD10, CD138 and MUM-1 in Diffuse Large B-Cell Lymphomas: A Cohort Study. In, Proceedings, : 24th World Congress of Pathology and Laboratory Medicine, (International) (24 Aug 2007)
  33. Dendritic cells and cytokine levels as predictors of acute graft-versus-host disease in allogeneic stem cell transplantation. , 24th World Congress of Pathology and Laboratory Medicine 2007 (International) (20 Aug 2007 - 24 Aug 2007)
  34. Dendritic cells and cytokine levels as predictors of acute graft-versus-host disease in allogeneic stem cell transplantation, 24th World Congress of Pathology and Laboratory Medicine (20 Aug 2007)
  35. The Antigen Expressions of BCL-2, BCL-6, CD10, CD138 and MUM-1 in Diffuse Large B-Cell Lymphomas: A Cohort Study., 24th World Congress of Pathology and Laboratory Medicine (20 Aug 2007)
  36. Teicoplanin-induced aplastic anemia., 6th Malaysian National Haematology Scientific Meeting (National) (21 Apr 2006)
  37. Treatment of refractory idiopathic thrombocytopenia purpura with the anti-CD20 monoclonal antibody Rituximab, 6th Malaysian National Haematology Scientific Meeting (National) (21 Apr 2006)
  38. Treatment of refractory idiopathic thrombocytopenia purpura with the anti-CD20 monoclonal antibody Rituximab, 6th Malaysian National Haematology Scientific Meeting, April 2006.  (National) (18 Apr 2006)
  39. Teicoplanin-induced aplastic anemia, 6th Malaysian National Haematology Scientific Meeting,  (National) (18 Apr 2006)
  40. Adult Allogeneic Hematopoetic Stem Cell Transplantation-UMMC experience, 5th Malaysian National Haematology Scientific Meeting (National) (16 Apr 2004)
  41. A Clinical report of Diffuse Large B cell Lymphoma in University Malaya Medical Centre, 5th Malaysian National Haematology Scientific Meeting (16 Apr 2004)
  42. Case Report: Candida Parapsilosis Cellulitis. ., 5th Malaysian National Haematology Scientific Meeting (16 Apr 2004)
  43. Interdigitating Dendritic Cell Sarcoma, . 5th Malaysian National Haematology Scientific Meeting, April 2004. (National) (09 Apr 2004)
  44. A Clinical report of Diffuse Large B cell Lymphoma in University Malaya Medical Centre., 5th Malaysian National Haematology Scientific Meeting, (National) (09 Apr 2004)
  45. Adult Allogeneic Hematopoetic Stem Cell Transplantation-UMMC experience, 5th Malaysian National Haematology Scientific Meeting, (National) (09 Apr 2004)
  46. High dose therapy with autologous hematopoeitic stem cell transplantation in poor risk Non-Hodgkin Lymphoma- Malaysian Experience. , 2003 Pan Pacific Lymphoma Conference (International) (15 Jul 2003)
  47. Low dose thalidomide as a treatment for relapsed/refractory multiple myeloma. , 8Th Annual Congress of the European Hematology Association, June 2003  (International) (25 Jun 2003)
  48. Mycophenolate mofetil and aplastic anemia. , 8Th Annual Congress of the European Hematology Association, June 2003  (International) (25 Jun 2003)
  49. Mycophenolate mofetil and aplastic anemia., 8Th Annual Congress of the European Hematology Association (International) (06 Jun 2003)
  50. Low dose thalidomide as a treatment for relapsed/refractory multiple myeloma., 8Th Annual Congress of the European Hematology Association (01 Jan 2003)
  51. Bleeding tendency in a thrombophilia state., The 4th National conference of Hematology 2002, (National) (12 Apr 2002)
  52. Bleeding tendency in a thrombophilia state, The 4th National conference of Hematology 2002, March 2002. (National) (20 Mar 2002)
  53. The development of autoimmune disease in immune thrombocytopenia purpura patients a long term follow up of 72 Asian patients., 42nd Annual meeting of American Society of Hematology. (08 Dec 2000)
  54. The development of autoimmune disease in immune thrombocytopenia purpura patients a long term follow up of 72 Asian patients., 42nd Annual meeting of American Society of Hematology. San Francisco, California,  (International) (04 Dec 2000)
  55. Drug induced agranulocytosis treated with hematopoietic growth factor A report of 11 patients., 42nd Annual Meeting of American Society of Hematology, San Francisco, California. Blood 2000 (International) (04 Dec 2000)
  56. BFM B cell protocol as salvage chemotherapy for relapsed and refractory high grade Non-Hodgkin Lymphoma B cell type, 28th World Congress of the International Society of Hematology (International) (27 May 2000)
  57. Use of BFM B cell protocol as salvage chemotherapy for relapsed and refractory high grade Non Hodgkin Lymphoma B cell type The University Hospital Experience, between August 1997-December 1999., The 3rd National Conference of Haematology 2000, Kuala Lumpur, April 2000. (National) (10 Apr 2000)
PRESENTER
  1. The evolutionary tales of hematology, UM inaugural lecture , FOM, UM (University) (26 Jan 2021 - 26 Jan 2021)
  2. The Asia-Pacific Myeloma and Related Diseases Registry: Preliminary Results of Real-World Treatment Patterns and Clinical Outcomes, 62nd American Society of Haematology annual meeting 2020 (20 Nov 2020)
  3. Incidence and risk factors associated with peripherally inserted central catheter related complications in adult hematological cancer patients, 17th Malaysian Society of Haematology scientific meeting (11 Sep 2020)
  4. The effect of single session 30-minutes mindful breathing on fatigue reduction among hematology malignancy patients, 17th Malaysian Society of Haematology scientific meeting (11 Sep 2020)
  5. Impact of donor chimerisms monitroing following allogenic stem cell transplantation : single centre experience in Malaysia,, 17th Malaysian Society of Haematology scientific meeting (10 Sep 2020)
  6. Case series of HIV associated lymphoma treated in UMMC, 17th Malaysian Society of Haematology scientific meeting (10 Sep 2020)
  7. Early disease progression in diffuse large B cell lymphoma associated clinical features and prediction tool, 17th Malaysian Society of Haematology scientific meeting (10 Sep 2020)
  8. Evolution of Haematopoietic stem cell transplant programs in Malaysia, 17th Malaysian Society of Haematology Scientific Meeting (10 Sep 2020)
  9. Case series of AL amyloidosis in University Malaya Medical Centre,, 17th Malaysian Society of Haematology Scientific Meeting (10 Sep 2020)
  10. PBM and impact on clinical practoce, Patient Blood Management Workshop, UMMC (University) (01 Jul 2019 - 01 Sep 2019)
  11. Quality of life among lymphoma survivors in developing country., ESMO Asia 2016 congress (01 Dec 2015)
  12. JAK2 V617F mutation in combination of ASXL1, DNMT3, TET2, U2AF1 and RUNX1 variants is associated with severe clinical phenotypes in primary myelofibrosis., EHA 2015 (01 Dec 2015)
  13. Ethnic variation in Interleukin-6 -174G/C polymorphism in malaysian population, Malaysian society of haematology Xth scientific meeting (26 Apr 2013 - 28 Apr 2013)
  14. The epidemiology of invasive fungal infection in patients with haematological diseases in a tertiary centre in Malaysia, malaysian society of haematology xth scientific meeting (26 Apr 2013 - 28 Apr 2013)
OTHERS
  1. myeloma and AML, Art of heamatology  (National) (18 Oct 2015)
  2. thrombosis session , MSh2015 scientific meeting  (National) (24 Apr 2015 - 25 Apr 2015)
  3. 12th Malaysian National Haematology Scientific Meeting 2015, 12th Malaysian National Haematology Scientific Meeting 2015 (National) (24 Apr 2015 - 25 Apr 2015)
  4. myeloma and lymphoma , haematology updates 2014 (National) (23 Aug 2014 - 23 Aug 2014)
  5. bridging the gap of IFI management, evening symposium on IFI management, MSD, MSH  (Others) (07 May 2012)

ACADEMIC/PROF. SERVICES


Evaluation
  1. (2022) Department of Medicineresearch Support Fund (Rsf), Cycle 3/2022, University, (Reviewer)
  2. (2022) Quality of Life in Brazilian Medical Students: a Systematic Review and Meta-Analysis, International, (Reviewer)
  3. (2022) Internal Medicine Master Student Thesis, National, (External Examiner)
  4. (2022) Master of Internal Medicine Part 3 Thesis Examination, National, (External Examiner)
  5. (2022) Mygrants, External Grant Frgs, University, (Reviewer)
  6. (2022) Review, International, (Reviewer)
  7. (2022) Disciplinary Panel, National, (Reviewer)
  8. (2021) 'St Jude Total Therapy Studies from I to Xvii for Childhood Acute Lymphoblastic Leukemia; a Brief Review'., International, (Reviewer)
  9. (2021) Assessor for Phd Project, University, (Internal Assessor)
  10. (2021) Judge for Posters, National, (Reviewer)
  11. (2021) Expression Dynamics of The Immune Mediators Arg1, Tbet, Ciita, Il10 and Tgfb1 in Chronic Myeloid Leukaemia Patients During The First Year of Imatinib Therapy, International, (Reviewer)
  12. (2021) Interviewer for M Med, University, (Internal Assessor)
  13. (2021) Reviewer of Umsc Care Fund, University, (Reviewer)
  14. (2021) Specific Il10 Promoter Polymorphisms is Associated With Survival in Pediatric Hodgkin Lymphoma, International, (Reviewer)
  15. (2021) Efficacy and Safety of Gemcitabine and Docetaxel Protocol in Patients With Refractory and Relapsed Non Hodgkin Lymphoma: Single Institutional Prospective Phase Ii Study, International, (Reviewer)
  16. (2021) Examiner for Msh Clinical Haematology Exit Exam, National, (External Examiner)
  17. (2021) Mygrants Reviewer, University, (Internal Evaluator)
  18. (2021) Review Article- Fluctuation of Qpcr is Level Beyond 0.1% Is, National, (Reviewer)
  19. (2021) APPOINTMENT AS A PANEL REVIEWER UMSC CA.R.E FUND RESEARCH GRANT 2021 APPLICATION , (Reviewer)
  20. (2021) Malaysian Society of Haematology part 2 specialist training examination , (External Examiner)
  21. (2020) Saudi Medical Journal, (Reviewer)
  22. (2020) Frontiers in Clinical Drug Research Haematology, (Reviewer)
  23. (2020) UMSC CA.R.E Fund Research Grant cycle 1/2020, (Reviewer)
  24. (2020) Journal of Integrative Medicine , (Reviewer)
  25. (2020) Cancer Medicin, (Reviewer)
  26. (2020) Expert Review of Precision Medicine and Drug Development , (Reviewer)
  27. (2019) Medical journal of Malaysia, (Reviewer)
  28. (2017) MASTER OF MEDICAL SCIENCE (RESEARCH MODE)- internal examiner MD MIRAZUL ISLAM (BANGLADESH) (MGN140042) title Cytokines and Chemokines Profiling of Adult Malaysian Acute Myeloid Leukemia (AML) Patients and Analysis of Molecular Abnormalities , (Internal Examiner)
  29. (2016) review an article OncoTargets and Therapy , (Reviewer)
  30. (2013) instituting robust in house karyotyping as part of standard diagnostic and management for children with acute lymphoblastic leukemia , (Internal Examiner)
  31. (2012) identification of unbalanced genomic abberations by array CGH in patient with chronic myeloid leukemia on imtinib treatment , (Internal Examiner)
  32. (2012) clinical haematology exit exmainer, (External Examiner)
  33. (2011) master of medical science-- thesis : quantitative RT-PCR analysis of wilms tumour 1 (WT1) gene for minimal residual disease monitoring in childhood acute myeloid leukemia, (Internal Examiner)
  34. (2010) examiner for clinical haematology exit examination , (External Examiner)
  35. (2010) malaysian society of haematology 7th national scientific meeting, (Scientific Committee)
  36. (2009) master of medical science thesis-- P16 tumour suppressor gene in diffuse large b cell lymphoma , (Internal Examiner)
  37. (2007) national standards for cord blood banking and transplantation -- ministry of health, (working group member)
  38. (2006) national organ , tissue and cell transplantation policy under ministry of health malaysia , (working group member)
  39. (2001) examiner for long case and short case and OSPE for MBBS phase 3A, phase 3B and Master of internal medicine stage 1 and 2 , (Internal Examiner)
Contribution to external organisation
  1. (2023) Technical Committee in Core Treatment Area- Haematology, National, (Technical Advisor)
  2. (2023) Panel Pakar Penasihat Pbkd Cell and Gene Therapy, National, (Expert Advisor)
  3. (2023) Scientific Committee for Asia Pacific Blood and Marrow Transplantaiton, International, (Expert Advisor)
  4. (2023) Executive Committee of The International Myeloma Foundation's Asian Myeloma Network (Amn), International, (Expert Advisor)
  5. (2022) Jawatankuasa Kerja Ubat-Ubatan Hematologi Kementerian Kesihatan Malaysia, National, (Technical Advisor)
  6. (2022) Subspecialty Education Committee, Medical Education Committee, National, (Expert Advisor)
  7. (2021) Cml Advisory Board Malaysia Meeting, National, (Expert Advisor)
  8. (2021) Chairperson to Advisory Board, National, (Expert Advisor)
  9. (2021) 1 St High Dose Iv Iron Malaysian Haematologists Advisory Board Meeting, National, (Expert Advisor)
  10. (2021) Chairperson, National, (Technical Advisor)
  11. (2021) Malaysia Covid-19 Advisory Board Meeting, National, (Expert Advisor)
  12. (2021) Clinical Guidelines for Covid-19 Vaccination, National, (Technical Advisor)
  13. (2021) Conjoint Associate Professor, International, (Adjunct/Visiting Professors)
  14. (2021) reviewer of CPD points for clinical haematology, Academy of medicine, Malaysia
  15. (2021) scientific committee member , Asia Pacific Blood and marrow transplantation group
  16. (2021) Clinical guidelines on COVID -19 vaccination second edition, Ministry of Health
  17. (2020) steering committee, Asia-Pacific Myeloma & Related Diseases Registry (APAC MRDR)
  18. (2019) Conjoint Associate Professor , University of Newcastle, International
  19. (2018) Asian myeloma network member, Asian Myeloma Network, International
  20. (2018) organizing committee, Malaysian Society of Haematology
  21. (2018) executive committee for policy and program advice, Asian Myeloma Network, Intermational Myeloma Foundation
  22. (2018) review of guidelines on stem cell research, KKM, (MOH)
  23. (2017) Updates on Haematological Neoplasms, Malaysian Society of Haematology and faculty of medicine
  24. (2013) MBBS phase3B faculty coordinator, University Malaya ,faculty of medicine
  25. (2012) training committee chairperson for clinical haematology , malaysian society of haematology
  26. (2011) curriculum restructuring for MBBS for haematology , University Malaya
  27. (2009) National Standard for Stem Cell Transplantation -, National, (Resource Person)
  28. (2008) National Standards for Cord Blood Banking and Transplantation, National, (Technical Advisor)
  29. (2007) National Organ, Tissue and Cell Transplantation Policy, National, (Expert Advisor)
  30. (2003) CPG for adult vaccination, KKM, Academy of Medicine, Malaysian society of infection and chemotherapy
  31. (2001) Consensus Guildelines for The Management of Esbl Producing Organism, National, (Resource Person)
Contribution to event
  1. (2022) Invited Speaker- Low Platelets At Due Date ! The Options, International, (Panelist/Moderator)
  2. (2022) Car T Cell Therapy, National, (Panelist/Moderator)
  3. (2021) Moderator, National, (Panelist/Moderator)
  4. (2021) Chairperson, International, (Panelist/Moderator)
  5. (2021) Chairperson, International, (Panelist/Moderator)
  6. (2021) Invited Speaker, International, (Panelist/Moderator)
  7. (2021) Invited Speaker, University, (Panelist/Moderator)
  8. (2021) Chairperson, National, (Panelist/Moderator)
  9. (2021) Chairperson for Msh Annual Scientific Meeting, National, (Panelist/Moderator)
  10. (2021) Panel, International, (Panelist/Moderator)
  11. (2021) Chairperson, National, (Panelist/Moderator)
  12. (2021) Invited Speaker, National, (Panelist/Moderator)
  13. (2021) Invited Speaker, University, (Panelist/Moderator)
  14. (2021) Panelist, National, (Panelist/Moderator)
  15. (2021) Chairperson, National, (Panelist/Moderator)

SUPERVISION


Postgraduate Student
PhD/ Doctoral
  1. (2024) Role of RUNX1 in plasma cell differentiation in Multiple myeloma patients, TANG TING FANG
  2. (2022) Identification of microRNAs and mRNAs Associated with R-Chop Chemotherapy Resistance and Disease Progression in Patients with Diffuse Large B-Cell Lymphoma, TING CHOO YUEN
  3. (2020) Role of RUNX1 in plasma cell differentiation in Multiple myeloma patients, TANG TING FANG
  4. (2020) MOLECULAR GENETICS IN HEMATOLOGICAL MALIGNANCIES, TING CHOO YUEN
  5. (2019) MOLECULAR GENETICS IN HEMATOLOGICAL MALIGNANCIES, TING CHOO YUEN
  6. (2018) Myeloma In Malaysia, Cheong Chin Sum
  7. (2016) Comparing the Quality of Life and Treatment Satisfaction between Patients on Warfarin and Direct Oral Anticoagulants: A Cross-Sectional Study., Diana Ng Leh Ching (M0100108)
  8. (2016) clinical haematology subspecialty training, Shasha Khairullah
  9. (2014) Molecular Analysis of Various Candidate Genes with Lymphoproliferative Disorders (LPDs) and Association with Methotrexate Related Toxicities and Serum Concentrations in Adult Multiethnic Population., SUJATHA A/P SUTHANDIRAM
  10. (2014) erectile dysfunction among male haematological patients in UMMC, Henning Loo
  11. (2013) treatment outcome of multiple myeloma patients in UMMC, Tengku Hidayat tengku Ahmad
Master
  1. (2024) Elucidating the Role of Gut Microbiome in Relation to Febrile Neutropenia in Acute Leukaemia Patients Undergoing Chemotherapy in Malaysia, NAJIHAH BINTI HUSSEIN
  2. (2020) retrosepective study on impact of CMV infection in transplant patients, Norr Yuhyi Bin Sulaiman
  3. (2020) retrosepective study on impact of CMV infection in transplant patients, Noor Yuhyi bin Sulaiman
  4. (2020) Rehabilitation Needs in Lymphoma Patients a single centre experience, Pamela Chia Shook Yen
  5. (2020) Myeloproliferative neoplasm registry in UMMC, Baizura Zolkafli
  6. (2020) Master of internal medicine, Dr Sivaraj Xaviar
  7. (2020) Master of internal medicine, Dr Karen Jit Kaur Gill A/P Sarjit Singh
  8. (2020) elucidating the role of gut microbiome in relation to the outcomes of patients with acute leukemias: a malaysian perspective, Najihah Hussein
  9. (2017) Master of internal medicine, Suganthi A/P Ramadas
  10. (2017) Master of internal medicine, Ong Wan Feng
  11. (2017) Master of internal medicine, Cheng Shian feng
  12. (2016) PICC related infection, Lee Kee Wei
  13. (2014) Quality of life in lymhoma patients, Diana Ng
  14. (2011) quality of life analysis in patients after haeatopoietic stem cell transplantation in UMMC, Henning Loo Cheng Kien
  15. (2011) a study of invasive fungal infections in haematological patients in UMMC, Ting Seng Kiat
  16. (2009) autologous peripheral blood stem cell collection:factors that influences the yield of stem cells, Mohd Faizal Abdul Latiff
  17. (2008) Association study of single nulceotide polymorphisms in selected candidate genes and non-hodgkin lymphoma in Malaysian populations, Tan mei Chee
  18. (2004) Chronic Myeloid Leukemia and imatinib, Bee Ping Chong
  19. (2002) pharmacogenetics of inter-ethnics variation in warfarin sensitivity using candidategene and genomic wide approach, Ku Chee Seng

TEACHING


Master
  1. (2020) MASTER - Master of Clinical Medicine (Leadership and Management _)
  2. (2020) MMED - Master of Internal Medicine
  3. (2020) MOB7003 - Stem Cell and Tissue Engineering
  4. (2019) MASTER - Master of Clinical Medicine (Leadership and Management _)
  5. (2019) MMED - Internal Medicine
  6. (2019) MOB7003 - Stem Cell and Tissue Engineering
  7. (2018) MMED - Internal Medicine
  8. (2018) MOB7003 - Stem Cell and Tissue Engineering
  9. (2017) MASTER - Master of Internal Medicine
  10. (2014) MASTER - Master of Internal Medicine
  11. (2014) MASTER -
  12. (2012) Mmed
  13. (2012) MASTER - Master of Internal Medicine
  14. (2010) MMED -
  15. (2010) MMED -
  16. (2008) Master of Medicine
  17. (2007) Master of Medicine
  18. (2006) MMED -
  19. (2005) Master of Medicine
  20. (2004) Master of Medicine
Bachelor
  1. (2020) MBBS - Ummp Haematology Block
  2. (2019) MBBS - MBBS Stage 3.1
  3. (2019) MBBS - MBBS Stage 3.2
  4. (2019) MBBS - Ummp Haematology Block
  5. (2018) MBBS - MBBS Stage 3.1
  6. (2018) MBBS - MBBS Stage 3.2
  7. (2018) MBBS - Ummp Haematology Block
  8. (2017) MBBS - MBBS Stage 3.1
  9. (2017) MBBS - MBBS Stage 3.2
  10. (2017) MBBS - Ummp Haematology Block
  11. (2016) MBBS
  12. (2016) MBBS - MBBS Stage 3.1
  13. (2016) MBBS - Ummp Haematology Block
  14. (2015) MBBS - MBBS 3.1 3.2
  15. (2015) MBBS - MBBS Stage 3.1
  16. (2015) MBBS - Ummp Haematology Block
  17. (2014) MBBS - Ummp Haematology Block
  18. (2013) MBBS Phase 3 A
  19. (2013) MBBS - Ummp Haematology Block
  20. (2012) MBBS Phase 3b
  21. (2012) MBBS - Ummp Haematology Block
  22. (2011) MBBS
  23. (2011) MBBS Phase 3a
  24. (2011) MBBS - MBBS
  25. (2011) MBBS -
  26. (2010) MBBS Phase 3a
  27. (2009) MBBS Phase 2
  28. (2009) MBBS Phase 3a
  29. (2009) MBBS - MBBS Stage 3.1
  30. (2008) MBBS Phase 2
  31. (2008) MBBS Phase 3a
  32. (2008) MBBS Phase 3b
  33. (2007) MBBS Phase 2
  34. (2007) MBBS Phase 3a
  35. (2006) Dental
  36. (2006) MBBS Phase 3b
  37. (2005) MBBS Phase 3a
  38. (2004) MBBS Phase 3a
  39. (2003) MBBS Phase 3a
  40. (2002) MBBS Phase 3a
  41. (2001) MBBS Phase 3a

SOCIAL RESPONSIBILITY ACTIVITIES


  • Organzing Committeee for Malaysian Society of Haematology National Scientific Meeting, (17 Sep 2020 - 19 Sep 2020)
  • Training Committee for Msh Subspecialty Training in Hematoloogy, (10 Sep 2020 - 01 Sep 2022)
  • Chairperson for Exam Committee for Msh for Subspecialty Training in Hematology, (10 Sep 2020 - 01 Sep 2022)
  • Vice President for Msh, (10 Sep 2020 - 01 Sep 2022)
  • Organizing Chairperson for Updates On Heamtology Seminar, (16 Nov 2019 - 16 Nov 2019)
  • Speaker for 5th Asean Federation of Hematology (Afh), (02 Nov 2019 - 03 Nov 2019)
  • Speaker for Immuno-Oncology Symposium in Conjunction With World Cancer Research Day, (24 Sep 2019 - 24 Sep 2019)
  • Speaker for Transplant Update, (26 Jul 2019 - 26 Jul 2019)
  • Speaker for Msh Scientific Meeting, (11 Apr 2019 - 13 Apr 2019)
  • Chairperson to Msh Scientific Meeting, (11 Apr 2019 - 13 Apr 2019)
  • Speaker for Nursing Seminar 5/2018 -Hematologi, (02 May 2018 - 02 May 2018)
  • Speaker for Malaysian Society of Haematology Annual Scientifuc Meeting, (19 Apr 2018 - 19 Apr 2018)
  • Invited Speaker for Masterclass in Systemic Chemotherapy, (10 Mar 2018 - 10 Mar 2018)
  • Accreditation Team for Cpd for Academy of Medicine, (01 Feb 2018 - 31 Dec 2021)
  • Speaker for Updates On Haematoligcal Neoplasm, (09 Dec 2017 - 09 Dec 2017)
  • Organizing Chairperson for Workshop On Updates On Haeamtological Neoplasm, (09 Dec 2017 - 09 Dec 2017)
  • Speaker for National Stem Cell Seminar, (10 Oct 2017 - 10 Oct 2017)
  • Speaker for Masterclass Systemic Cancer Therapy, (05 Mar 2017 - 05 Mar 2017)
  • Committee Member for Msh 2015 Meeting, (24 Apr 2015 - 25 Apr 2015)
  • Council Member Malaysian Society of Haematology, (01 Apr 2015 - 30 Apr 2018)
  • Subcommittee for Nsr Clincial Hematology, (04 Jan 2015 - 04 Jan 2016)
  • Speaker for Art of Hematology, (23 Nov 2014 - 24 Nov 2014)
  • Kkm Ahli Jawatan Kuasa Kerja Ubat Hematologi, (01 Jun 2014 - 31 Dec 2017)
  • Chairperson for Msh Invasive Fungal Infection Forum, (16 Mar 2013)
  • Speaker for Meet The Trainees At Haematology Upate 2013, (23 Feb 2013 - 23 Feb 2013)
  • Invited Panel Member for Fungal Infection Advisory Board, (16 Dec 2012)
  • Asean Federation of Haematology -- Chairperson for One Session, (08 Sep 2012)
  • Invited Speaker for Seminar Oncology for Nurses, (04 Sep 2012)
  • Saturday Teach in for Hematology, (12 May 2012)
  • Chairperson for Evening Symposium for Ifi, (07 May 2012)
  • Training Committee for Clinical Haematology -Msh 2012-2015, (24 Apr 2012 - 31 Mar 2015)
  • Speaker for Msh2012 Mini Summitt, (20 Apr 2012)
  • Training Committee for Msh Clincial Hematology, (01 Apr 2012 - 30 Apr 2018)
  • Malaysian Society of Haematology--Council Member, (17 May 2008 - 25 Apr 2012)
  • 7th National Scientific Meeting for Msh-Secretary Organising, (10 Apr 2008 - 12 Apr 2008)
  • Working Group Member for The National Standards for Cord Blood Banking and Transplantation, (01 Jan 2007 - 01 Jan 2008)
  • Consensus Guidelines for The Management of Extended Spectrum Beta- Lactamases Producing Organisms. Academy of Medicine/Malaysian Society of Infectious Disease and Chemotherapy. 2001& 2007, (01 Jan 2007 - 30 Dec 2007)
  • Working Group Members for National Organ, Tissue and Cell Transplantation Policy Ministry of Health 2007, (01 Jan 2006 - 01 Jan 2007)
  • Malaysian Society of Haematology-- Secretary, (17 Apr 2004 - 19 May 2008)
  • 5th National Haematology Scientificn Meeting- Orgnansiign Secretary, (09 Apr 2004 - 11 Apr 2004)